- Home
- TCBX vs ORGO Comparison
TCBX vs ORGO Comparison
Compare TCBX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- ORGO
- Stock Information
- Founded
- TCBX 2008
- ORGO 1985
- Country
- TCBX United States
- ORGO United States
- Employees
- TCBX N/A
- ORGO N/A
- Industry
- TCBX Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- ORGO Health Care
- Exchange
- TCBX Nasdaq
- ORGO Nasdaq
- Market Cap
- TCBX 481.8M
- ORGO 465.6M
- IPO Year
- TCBX 2021
- ORGO N/A
- Fundamental
- Price
- TCBX $36.35
- ORGO $4.51
- Analyst Decision
- TCBX Hold
- ORGO Buy
- Analyst Count
- TCBX 5
- ORGO 2
- Target Price
- TCBX $35.75
- ORGO $6.50
- AVG Volume (30 Days)
- TCBX 72.2K
- ORGO 895.4K
- Earning Date
- TCBX 07-23-2025
- ORGO 08-07-2025
- Dividend Yield
- TCBX N/A
- ORGO N/A
- EPS Growth
- TCBX 52.43
- ORGO N/A
- EPS
- TCBX 3.28
- ORGO N/A
- Revenue
- TCBX $182,318,000.00
- ORGO $458,760,000.00
- Revenue This Year
- TCBX $17.44
- ORGO $3.50
- Revenue Next Year
- TCBX $6.46
- ORGO $8.59
- P/E Ratio
- TCBX $11.10
- ORGO N/A
- Revenue Growth
- TCBX 20.25
- ORGO 5.35
- 52 Week Low
- TCBX $20.66
- ORGO $2.28
- 52 Week High
- TCBX $39.72
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- TCBX 53.78
- ORGO 53.20
- Support Level
- TCBX $35.03
- ORGO $4.67
- Resistance Level
- TCBX $39.72
- ORGO $5.15
- Average True Range (ATR)
- TCBX 1.37
- ORGO 0.28
- MACD
- TCBX -0.07
- ORGO -0.04
- Stochastic Oscillator
- TCBX 41.59
- ORGO 53.70
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.